SCHEMBL6174605

SCHEMBL6174605

CC(c1ccnc(C(=N)N)c1)C1NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 13/20 0.42
PDE2A O00408 7/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173480 0.89 IGF1R (0.41) IGF1RPDE2A
SCHEMBL6171578 0.85 LMNA (0.39) PDE2A
SCHEMBL6174049 0.85 IGF1R (0.46) IGF1R
SCHEMBL6173860 0.84 IGF1R (0.40) IGF1RPDE2A
SCHEMBL6177806 0.84 IGF1R (0.43) IGF1RPDE2A
SCHEMBL6175882 0.84 PDE2A (0.39) IGF1RPDE2A
SCHEMBL6174744 0.83 IGF1R (0.41) IGF1R
SCHEMBL6171919 0.83 IGF1R (0.41) IGF1RPDE2A
SCHEMBL6173932 0.82 IGF1R (0.40) IGF1R
SCHEMBL6173796 0.81 IGF1R (0.52) IGF1RPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed